Ortho Clinical Diagnostics
JP Morgan Healthcare Conference Day 2: Labcorp, Thermo Fisher Scientific, Abbott, Danaher, More
Highlights of the second day included Labcorp's update on its COVID-19 testing trends and Ortho Clinical's perspective on its proposed acquisition by Quidel.Â
Ortho Clinical Diagnostics Preliminary Q4 Revenues Rise 1 Percent
The firm's Q4 core revenue, excluding SARS-CoV-2 sales, is expected to increase to between $508 million and $510 million, up about 7 percent year over year.
Antibody assays cannot be used for a SARS-CoV-2 diagnosis, but some evidence is emerging that they could eventually detect immunity from the infection.
Nineteen companies went public during the year, with two offerings nabbing proceeds of more than $1 billion and two more above $500 million.Â
Ortho Clinical Diagnostics, Siemens Healthineers, Roche, and Others Obtain FDA Clearances in October
The FDA granted clearance to Roche for use of its Cobas Cdiff nucleic acid test, which detects the toxin B gene running on the firm's Liat point-of-care instrument.